Where in the world is Tim Whitten? That's a clue to what I think is going down. This 8K from yesterday would bother me if insiders hadn't loaded the boat right after the adoption, so I think it's an advance prep for a major overseas partnership. In fact, I'm seeing 20 as the new ground floor, at least in the eyes of the insiders! What a great couple of months we've had!
Where do you see at the "end of the month"? You could be right, but I found something that they will move in sometime during 2014:
On December 31, 2013, Insmed Incorporated (the “Company”) and Denver Road, LLC entered into a lease of laboratory and office space totaling approximately 27,435 square feet in Bridgewater, New Jersey. The lease term ends November 30, 2019. Under the lease, the Company is obligated to pay base rent of $438,960 per year in the initial year of the lease, which base rent rises annually and equally until it reaches $507,547 in the final year of the lease. The Company also is obligated to pay for certain utilities, taxes and other expenses incurred by the landlord in excess of specified levels. The lease provides the Company with certain options to lease additional space in the same building. The Company will relocate its operations to the Bridgewater facility during 2014. A copy of the lease is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference
I saw that Shire freed up some capital today with a sale,be nice if some of it would come our way by way of Premacure. Somethings brewing that`s for sure,exciting times happening and will keep getting more and more exciting the closer we get to the March data.
Pianoman - I wouldn't rule iPlex finally coming back into the mix of things. Roche has every has everything to lose by not making a deal with insm. Plus throw Merck in the mix. The one thing I do wonder is how a study was done on muscular dystrophy with iPlex with the supply of iPlex being depleted years ago. June 25th 2013 article said iPlex is manufactured by Insmed. But I also do see the Japanese partnership happening too.
What's your thoughts?
In addition, to test the translational potential of this combination therapy, the researchers systemically treated Bax deficient dystrophic mice with recombinant human IGF-1 (IPLEX TM, manufactured by Insmed Inc).